Form 4: Precigen CEO Reports Stock Transaction
Insider Transaction (Form 4)
Helen Sabzevari, President and CEO of Precigen, Inc., reported multiple transactions in common stock on August 23, 2026.
Summary
- Option exercise/conversion: acquired 20,833 Common Stock on August 23, 2026; holds 3,789,705 after (Direct).
- Tax/exercise-price withholding: disposed of 10,184 Common Stock at $7.20 ($73,325) on August 23, 2026; holds 3,779,521 after (Direct).
- Option exercise/conversion: disposed of 20,833 Restricted Stock Units on August 23, 2026; holds 229,167 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Helen Sabzevari — Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-23 | Option exercise/conversion | Common Stock | 20,833 | — | — | 3,789,705 |
| 2026-08-23 | Tax/exercise-price withholding | Common Stock | 10,184 | $7 | $73.3K | 3,779,521 |
| 2026-08-23 | Option exercise/conversion | Restricted Stock Units | 20,833 | — | — | 229,167 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-23 | Option exercise/conversion (20,833 shares) |
| 2026-08-23 | Tax/exercise-price withholding (10,184 shares) |
| 2026-08-23 | Option exercise/conversion (20,833 shares) |
Keywords
insider transaction, Form 4, PGEN, PRECIGEN, INC., neutral, Helen Sabzevari
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.